27 min

#4 - Unraveling the Complexities of Clinical Pharmacy in Heart Failure Management: A Discussion with Dr. Craig Beavers Action Potential

    • Business News

Welcome back to Action Potential, join us this week as we welcome Dr. Craig Beavers, Associate Professor, UK College of Pharmacy
What you'll get from this episode:
The journey to becoming a clinical pharmacist.Managing heart failure and cardio-oncology.Navigating polypharmacy challenges in patient care.The evolving role of clinical pharmacists in healthcare.The importance of patient-focused care and medication management.Future advancements in clinical pharmacy and patient monitoring.Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."
Learn more about Craig Beavers: https://www.linkedin.com/in/craig-beavers-pharmd-facc-faha-fccp-bccp-cacp-420b0a68/And for more on UK College of Pharmacy: https://pharmacy.uky.edu/
Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

Welcome back to Action Potential, join us this week as we welcome Dr. Craig Beavers, Associate Professor, UK College of Pharmacy
What you'll get from this episode:
The journey to becoming a clinical pharmacist.Managing heart failure and cardio-oncology.Navigating polypharmacy challenges in patient care.The evolving role of clinical pharmacists in healthcare.The importance of patient-focused care and medication management.Future advancements in clinical pharmacy and patient monitoring.Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."
Learn more about Craig Beavers: https://www.linkedin.com/in/craig-beavers-pharmd-facc-faha-fccp-bccp-cacp-420b0a68/And for more on UK College of Pharmacy: https://pharmacy.uky.edu/
Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

27 min